Subacute combined degeneration of the spinal cord of toxic etiology (clinical case)
https://doi.org/10.17650/2073-8803-2023-18-4-44-48
Abstract
For more than two hundred years after its discovery, nitric oxide (I) has been widely used in medicine as an anesthetic, in the car industry as an engine performance enhancer, in the food industry as a preservative, and, unfortunately, among young people as a mild narcotic substance. Despite the widespread opinion that there is no harm from the use of “laughing gas” for recreational purposes, in the literature and in practice, there are a lot of cases when patients suffer from various complications, including neurological ones, caused precisely by the use of nitric oxide (I). One of the main mechanisms of the pathological effects of nitrous oxide on the nervous tissue is the inactivation of vitamin B12. This has been proven by studying the physicochemical properties of the gas, the effect on the organisms of laboratory animals, the change in the concentration of certain substances in the human body, and also by the use of cyanocobalamin for the treatment of these patients. This article describes a clinical case of the development of myelopolyneuropathy caused by the toxic effects of nitric oxide (I).
About the Authors
A. A. Kondratov
M.F. Vladimirskiy Moscow Regional Research Clinical Institute
Russian Federation
Russian Federation
61/2 Shchepkina St., Moscow 129110
A. S. Kotov
M.F. Vladimirskiy Moscow Regional Research Clinical Institute
Russian Federation
Russian Federation
61/2 Shchepkina St., Moscow 129110
References
1. Suponeva N.A., Grishina D.A., Grozova D.A. Neurological complications and pathogenetic therapy in chronic intoxication with nitrous oxide (“laughing gas”) among visitors to nightclubs. Nervno-myshechnye bolezni = Neuromuscular Diseases 2020;10(3):49–62. (In Russ.)
2. Li Y., Dong J., Xu R. et al. Clinical epidemiological characteristics of nitrous oxide abusers: A single-center experience in a hospital in China. Brain Behav 2021;11(12):e2416. DOI: 10.1002/brb3.2416
3. McCormick J.P., Sharpe S., Crowley K. et al. Nitrous oxideinduced myeloneuropathy: an emerging public health issue. Ir J Med Sci 2023;192(1):383–8. DOI: 10.1007/s11845-022-02945-8
4. Savage S., Ma D. The neurotoxicity of nitrous oxide: the facts and "putative" mechanisms. Brain Sci 2014;4(1):73–90. DOI: 10.3390/brainsci4010073
5. Xiang Y., Li L., Ma X. et al. Recreational nitrous oxide abuse: Prevalence, neurotoxicity, and treatment. Neurotox Res 2021;39(3):975–85. DOI: 10.1007/s12640-021-00352-y
6. Van Amsterdam J., Nabben T., van den Brink W. Recreational nitrous oxide use: Prevalence and risks. Regul Toxicol Pharmacol 2015;73(3): 790–6. DOI: 10.1016/j.yrtph.2015.10.017. Available at: https://www.sciencedirect.com/science/article/pii/S027323001530101X.
Review
For citations:
Kondratov A.A., Kotov A.S. Subacute combined degeneration of the spinal cord of toxic etiology (clinical case). Russian Journal of Child Neurology. 2023;18(4):44-48. (In Russ.) https://doi.org/10.17650/2073-8803-2023-18-4-44-48
Views:
466
Email this article 